It was demonstrated that 1,25(OH)2D3 is a significant contributor to the expression of insulin receptors, insulin signaling in skeletal muscles and the reduction in hyperglycemia and hyperinsulinemia (Girgis et al., 2013). The gene discussed is INS; the disease is hyperinsulinism.